-
272%
500 gene and KRAS Mutation
Identification of therapeutically relevant gene mutations for Cancer -
272%
500 gene & EGFR mutation
Identification of therapeutically relevant gene mutations for Cancer -
272%
500 gene and KRAS/NRAS/BRAF Mu ...
Identification of therapeutically relevant gene mutations for Cancer500 gene and KRAS/NRAS/BRAF Mu ...
Identification of therapeutically relevant gene mutations for Cancer -
222%
BRCA1 BRCA2 TP53 Gene Testing ...
Panel of BRCA1&2 Genes - 237%
-
272%
Circulating Tumor Cells & ...
Identification of therapeutically relevant gene mutations for Cancer -
238%
Clinical Exome Test
multi gene panel. Gene list will be shared on request -
249%
Endopredict
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer - 253%